title: [Recent topics on important drugs for H. pylori eradication: Lansoprazole].
authors.affiliation: Division of Gastroenterology, Hyogo College of Medicine.
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Fukuda
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Tomita
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Koizuka
authors.forename: Nobuo
authors.initials: N
authors.lastname: Aoyama
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D005745:Gastric Acidity Determination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D054328:Proton Pump Inhibitors
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole